PubMed COVID-19 Clinical Care

We report the safety and immunogenicity of fractional and full dose Ad26.COV2.S and BNT162b2 in an open label phase 2 trial of participants previously vaccinated with a single dose of Ad26.COV2.S, with 91.4% showing evidence of previous SARS-CoV-2

CONCLUSIONS: Low-value cancer care remained prevalent throughout the pandemic. Policy makers should consider changes to payment and incentive design to turn the tide against low-value cancer care.

This is the second of three reports on economic geography. It focuses on research that addresses issues deemed to be both urgent and generative of crisis. This report focuses on the crisis created by the emergence of COVID-19. While the virus may

This study examines Turkish online news media coverage of the COVID-19 outbreak in the country. It explores media framing narratives, particularly how they reflected and promoted elite polarization or consensus in the COVID-19 debate. The findings

Adapting to the remote working environment has been one of the most visible challenges for many organizations during the COVID-19 pandemic. As employee creativity helps organizations' survival and resilience during times of crisis, this study aims to

The immunogenicity and safety of the concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine (Split Virion) (QIIV) in Chinese adults are unclear. In this open-label, randomized controlled trial

In 1978, at Alma Ata, it was clearly claimed that inequities in health are simply not acceptable. Each individual should be able to achieve the highest possible level of health (in its holistic definition). This should be considered as a fundamental

CONCLUSION: The study found that there were poor health communication practices in preventing and controlling NCDs. Thus, professional practice of health communication about NCDs must be prioritized, and emphasis should be given to inter-sectoral

RAND Europe was commissioned by the Novo Nordisk Foundation to conduct a study on pathogen surveillance and current initiatives. The study aims to provide an overview of the pathogen surveillance space internationally and the stakeholders involved

CONCLUSIONS: Pharmacists are to prioritize a healthy work-life balance, which includes avoiding prolonged shifts >8 h, regular physical exercise and promote open communication among colleagues to address workplace concerns.